Clinical trial
Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease
NCT02150551 is registered in ClinicalTrials.gov with Catherine Bollard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease
- Lead sponsor
- Catherine Bollard
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 7, 2018
- Completion date
- September 5, 2018
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.